These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8455949)
1. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Chang KS; Fan YH; Stass SA; Estey EH; Wang G; Trujillo JM; Erickson P; Drabkin H Oncogene; 1993 Apr; 8(4):983-8. PubMed ID: 8455949 [TBL] [Abstract][Full Text] [Related]
2. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia. Maruyama F; Yang P; Stass SA; Cork A; Freireich EJ; Lee MS; Chang KS Cancer Res; 1993 Oct; 53(19):4449-51. PubMed ID: 8402610 [TBL] [Abstract][Full Text] [Related]
3. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193 [TBL] [Abstract][Full Text] [Related]
4. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242 [TBL] [Abstract][Full Text] [Related]
5. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Erickson PF; Robinson M; Owens G; Drabkin HA Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293 [TBL] [Abstract][Full Text] [Related]
6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
7. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. van de Locht LT; Smetsers TF; Wittebol S; Raymakers RA; Mensink EJ Leukemia; 1994 Oct; 8(10):1780-4. PubMed ID: 7523801 [TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization. Paskulin GA; Philips G; Morgan R; Sandberg A; Richkind K; Borovik C; McGavran L; Rabinovich N; Dietz-Band J; Erickson P; Drabkin H; Varella-Garcia M Genes Chromosomes Cancer; 1998 Feb; 21(2):144-51. PubMed ID: 9491326 [TBL] [Abstract][Full Text] [Related]
10. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913 [TBL] [Abstract][Full Text] [Related]
11. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289 [TBL] [Abstract][Full Text] [Related]
13. Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts. Takenokuchi M; Yasuda C; Takeuchi K; Nakamachi Y; Mukai M; Kondo S; Kumagai S; Saigo K; Murayama T; Koizumi T; Tatsumi E Clin Lab Haematol; 2004 Apr; 26(2):107-14. PubMed ID: 15053804 [TBL] [Abstract][Full Text] [Related]
14. [Rearrangements and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b]. Wang J; Xiao Z; Hao Y Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):399-402, 445. PubMed ID: 7553157 [TBL] [Abstract][Full Text] [Related]
15. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037 [TBL] [Abstract][Full Text] [Related]
16. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells. Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927 [TBL] [Abstract][Full Text] [Related]
17. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21). Kwong YL; Chan V; Wong KF; Chan TK Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132 [TBL] [Abstract][Full Text] [Related]
18. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Nucifora G; Dickstein JI; Torbenson V; Roulston D; Rowley JD; Vardiman JW Leukemia; 1994 Sep; 8(9):1533-8. PubMed ID: 7522291 [TBL] [Abstract][Full Text] [Related]
19. [Disappearance of residual disease confirmed by RT-PCR following induction chemotherapy in two hypoplastic leukemia patients with t(8;21)]. Sawada M; Tsurumi H; Yamada T; Hara T; Oyama M; Moriwaki H Rinsho Ketsueki; 1999 Apr; 40(4):311-7. PubMed ID: 10355140 [TBL] [Abstract][Full Text] [Related]
20. Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia. Yoo SJ; Chi HS; Jang S; Seo EJ; Seo JJ; Lee JH; Park HS; Park CJ Haematologica; 2005 Nov; 90(11):1493-501. PubMed ID: 16266896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]